Atlas Trials

Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation, and Donor Bone Marrow Transplant Followed by Donor Natural Killer Cell Therapy, Mycophenolate Mofetil, and Tacrolimus in Treating Patients With Hematologic Cancer

Clinical trial NCT00789776 · COMPLETED

Trial details

NCT number
NCT00789776
Sponsor
Fred Hutchinson Cancer Center
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAggressive Non-Hodgkin LymphomaDiffuse Large B-Cell LymphomaPreviously Treated Myelodysplastic SyndromeRecurrent Chronic Lymphocytic LeukemiaRecurrent Chronic Myelogenous Leukemia, BCR-ABL1 PositiveRecurrent Indolent Adult Non-Hodgkin LymphomaRecurrent Mantle Cell LymphomaRecurrent Plasma Cell MyelomaRecurrent Small Lymphocytic LymphomaRefractory Chronic Lymphocytic Leukemia
Start date
2008-10-13
Primary completion
2017-05-01
Enrollment
41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.